Skip to search formSkip to main contentSkip to account menu

Nevirapine

Known as: NVP, 6H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-, 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one 
A benzodiazepine non-nucleoside reverse transcriptase inhibitor. In combination with other antiretroviral drugs, nevirapine reduces HIV viral loads… 
National Institutes of Health

Related topics

Related topics

28 relations
24 HR Nevirapine 400 MG Extended Release Oral Tablet24 HR Nevirapine 400 MG Extended Release Oral Tablet [Viramune]Acquired Immunodeficiency SyndromeDrug Allergy

Broader (4)

Anti-HIV AgentsCytochrome P-450 CYP3A InducersPyridinesReverse Transcriptase Inhibitors

Narrower (5)

BI-RG-587BI-RH 448BI-RJ 70Nevirapine 200 MG Oral Tablet [Viramune]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000–2006
Combination antiretroviral therapy (cART) is changing, and this may affect the type and occurrence of side effects. We examined… 
Review
2007
Review
2007
Prevention of mother-to-child transmission services as a gateway to family-based human immunodeficiency virus care and treatment in resource-limited settings: rationale and international experiences.
Highly Cited
2007
Highly Cited
2007
Insulin-like growth factor-1 receptor and ligand targeting in head and neck squamous cell carcinoma.
Highly Cited
2004
Highly Cited
2004
Tumor Cell and Endothelial Cell Therapy of Oral Cancer by Dual Tyrosine Kinase Receptor Blockade
Expression of the epidermal growth factor (EGF) and activation of its receptor (EGFR), a tyrosine kinase, are associated with… 
Highly Cited
2002
Highly Cited
2002
1-[2-[(5-Cyanopyridin-2-yl)amino]ethylamino]acetyl-2-(S)-pyrrolidinecarbonitrile: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties.
Dipeptidyl peptidase IV (DPP-IV) inhibition has the potential to become a valuable therapy for type 2 diabetes. We report the… 
Highly Cited
2002
Highly Cited
2002
Dipeptidyl peptidase IV inhibition improves impaired glucose tolerance in high-fat diet-fed rats: study using a Fischer 344 rat substrain deficient in its enzyme activity.
This study was performed to determine the effects of a high-fat diet on glucose metabolism after an oral glucose challenge in… 
Highly Cited
2001
Highly Cited
2001
Anti-HIV activity of aromatic and heterocyclic thiazolyl thiourea compounds.
Highly Cited
1996
Highly Cited
1996
A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV‐infected patients
Objectives Nevirapine is a non-nucleoside reverse transcriptase inhibitor of HIV-1 which exhibits synergy in vitro with… 
Highly Cited
1989
Highly Cited
1989
Determination of the coding capacity of the M genome segment of nephropathia epidemica virus strain Hällnäs B1 by molecular cloning and nucleotide sequence analysis.
Highly Cited
1987
Highly Cited
1987
Complement activation by hydroxyethylmethacrylate-ethylmethacrylate copolymers.
Certain biomaterials, including nylon oxygenator and cellulosic dialysis membranes, are potent activators of human complement. In… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)